Cabaletta Bio, Inc.
CABA
$3.52
-$0.11-3.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.57% | 0.58% | -25.55% | -10.30% | -6.39% |
| Total Depreciation and Amortization | 0.87% | -26.28% | -3.51% | 3.63% | 10.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.98% | -3.66% | 32.01% | 25.82% | -12.34% |
| Change in Net Operating Assets | -849.77% | -94.71% | 233.41% | -206.02% | -0.83% |
| Cash from Operations | -2.42% | -13.42% | 1.22% | -33.22% | -13.77% |
| Capital Expenditure | -162.82% | 51.55% | 79.49% | -108.78% | -48.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -1.97% | -- | -- | 0.00% |
| Cash from Investing | 199.43% | -1.80% | -6,167.01% | -106.47% | -1.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -140.50% | 73.52% | -443.84% | 38.46% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 7,321.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,133.75% | -100.86% | 17,015.40% | -112.63% | 6,057.75% |
| Foreign Exchange rate Adjustments | 27.27% | -135.48% | 342.86% | 135.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.67% | -719.69% | 142.89% | -383.48% | 16.98% |